Chester County News and Community Website
AUDUBON, PA — Globus Medical, Inc. (NYSE: GMED) has announced a major leadership transition alongside preliminary second-quarter results that show continued momentum in its core spine and enabling technologies businesses.
Globus Medical Names Keith Pfeil as CEO, Posts Strong Q2 Sales Growth Read More
BLUE BELL, PA — BrightView Holdings, Inc. (NYSE: BV), the nation’s largest commercial landscaping services company, announced an update to its fiscal year 2025 financial guidance, highlighting expectations for record …
BrightView Updates 2025 Outlook, Reaffirms Record EBITDA Despite Revenue Challenges Read More
WILMINGTON, DE — The Chemours Company (NYSE: CC) issued an updated outlook for the second quarter of 2025, highlighting robust performance across several business segments. Notable gains are projected for …
Chemours Updates Second Quarter 2025 Outlook with Strong Gains in Key Segments Read More
PHILADELPHIA, PA — Five Below, Inc. (NASDAQ: FIVE) announced key leadership changes and an updated financial outlook for the first quarter of fiscal 2025. Co-founder and Executive Chair Tom Vellios …
Five Below Announces Leadership Transition and Raised Q1 2025 Guidance Read More
WILMINGTON, DE — InterDigital, Inc. (Nasdaq: IDCC) has significantly raised its first-quarter 2025 guidance after signing a new multi-year, royalty-bearing license agreement with a leading Chinese smartphone manufacturer. This agreement enhances …
InterDigital Updates Q1 2025 Outlook After Major Smartphone Licensing Deal Read More
LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: NXGL) this week issued a letter to its shareholders outlining robust financial guidance for 2024 and 2025, alongside updates on the company’s strategic growth initiatives …
NEXGEL Projects Over 100% Revenue Growth for Third Consecutive Year Read More
PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) has announced robust preliminary net product revenues for the fourth quarter and full year of 2024, with figures reaching $201 million …
Harmony Biosciences Reports Strong Revenue Growth and Outlines Ambitious 2025 Strategy Read More
YARDLEY, PA — Optinose (NASDAQ: OPTN) has announced preliminary unaudited net product revenue of $22.4 million for the fourth quarter of 2024, driven by sustained growth in prescriptions for XHANCE® (fluticasone …
Optinose Reports $22.4 Million in Preliminary Q4 Revenue for XHANCE Read More
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has shared its preliminary fourth quarter and full-year revenue figures for 2024, alongside robust guidance and strategic priorities for 2025. The report highlights …
Neuronetics Reports 2024 Revenue Growth, Reveals Optimistic 2025 Guidance Read More
PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) has revealed significant progress in its pipeline and operations, underscoring its focus on advancing rese-cel, a cell therapy candidate for autoimmune diseases. …
Cabaletta Bio Advances Autoimmune Therapy, Sets Strategic Goals for 2025 Read More